Dihydroxyfumaric acid

CAS No. 133-38-0

Dihydroxyfumaric acid( —— )

Catalog No. M32032 CAS No. 133-38-0

Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydroxyfumaric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.
  • Description
    Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133-38-0
  • Formula Weight
    148
  • Molecular Formula
    C4H4O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biochemical and Biophysical Research Communications, 1979,89(4):1239-1244.
molnova catalog
related products
  • 2-Undecanol

    2-Undecanol (Undecan-2-ol) is a male specific compound extracted from aeration of live Lobiopa insularis beetles. 2-undecanol is a flower emitted volatile, used by various species of Hymenoptera as a pheromone component.

  • R 892

    Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.

  • Lucidumol A

    Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM.